Showing results (521-530 of 673) with videos related to

Sort By:
Pageof 68
HIV Clinical Trials|December 1, 2012
Renal impairment is associated with coronary heart disease in HIV-positive menLucy J Campbell, Mitesh Desai, Aseel Hegazi, et al.
HIV Clinical Trials|December 1, 2012
Treatment of calcium and vitamin D deficiency in HIV-positive men on tenofovir-containing antiretroviral therapyAnneke Bech, Petra Van Bentum, Darryl Telting, et al.
HIV Clinical Trials|April 25, 2013
Immune Activation While on Potent Antiretroviral Therapy Can Predict Subsequent CD4+ T-Cell Increases Through 15 Years of TreatmentXinyan Zhang, Peter W Hunt, Scott M Hammer, et al.
HIV Clinical Trials|November 25, 2005
Pharmacokinetics of clarithromycin extended-release (ER) tablets in patients with AIDSMark A Jacobson, David P Nicolau, Christina Sutherland, et al.
HIV Clinical Trials|November 25, 2005
Human immunodeficiency virus (HIV) entry inhibitors (CCR5 specific blockers) in development: are they the next novel therapies?Vincent Idemyor
HIV Clinical Trials|November 13, 2009
Viral load decay in antiretroviral-naïve patients receiving once-daily tenofovir and emtricitabine plus twice-daily nevirapineAnthony Amoroso, Bruce L Gilliam, Rohit Talwani, et al.
HIV Clinical Trials|November 13, 2009
Rectal cell-associated HIV-1 RNA: a new marker ready for the clinicAlain Lafeuillade, Antoine Cheret, Gilles Hittinger, et al.
HIV Clinical Trials|November 17, 2017
HIV-1 resistance rarely observed in patients using darunavir once-daily regimens across clinical studiesErkki Lathouwers, Eric Y Wong, Donghan Luo, et al.
HIV Clinical Trials|January 4, 2019
Darunavir/cobicistat maintains the effectiveness of darunavir/ritonavir in HIV-infected patients under mono or dual therapyÁlvaro Mena, Purificación Cid, Carlos Dueñas, et al.
HIV Clinical Trials|December 7, 2017
Short-term cost and efficiency analysis of raltegravir versus atazanavir/ritonavir or darunavir/ritonavir for treatment-naive adults with HIV-1 infection in SpainAshley E Davis, Anita J Brogan, Bridgett Goodwin, et al.
Pageof 68